Welcome!
The ASHP-accredited PGY2 Oncology Pharmacy Residency at Nebraska Medicine offers a unique and stimulating learning environment which provides comprehensive clinical training in hematology and oncology pharmacy practice. The goal of the residency program is to develop clinical practitioners who specialize in the care of oncology patients and also have an interest in education and research. After orientation, residents will participate in ten months of clinical rotations in addition to longitudinal experiences in our outpatient infusion center and clinics, teaching, and clinical research.
Oncology Specific Practice Environment
-
Nebraska Medicine is a nationally respected cancer center and one of the founding members of the National Comprehensive Cancer Network (NCCN)
-
The Fred and Pamela Buffett Cancer Center, an entity of Nebraska Medicine and UNMC, integrates research and education with patient care to offer the most up-to-date treatments for a variety of cancers
-
Unique collaboration between Nebraska Medicine cancer physicians and UNMC researchers allows discoveries made in the laboratories to be taken directly to the patient
-
Recognized internationally for pioneering autologous transplantation for lymphoma, using peripheral stem cells as an alternative rescue product, conducting groundbreaking studies on various growth factors and performing transplants in alternate settings other than traditional inpatient hospital units
-
The outpatient transplant program employs a care model that allows patients and their care partners to play an active role in the treatment and recovery process following cancer care
Rotational Experiences
Required Rotations
Orientation (July – 4 weeks)
BMT/Leukemia/Cellular Therapy (6 weeks)
Medical Oncology/Hematology (4 weeks)
Pediatric Hematology/Oncology (4 weeks)
Infusion Center (4 weeks)
Gynecology Oncology Inpatient/Clinic (2 weeks)
Ambulatory Oncology Clinic – Heme/BMT (4 weeks)
Ambulatory Oncology Clinic – Solid Tumors (4 weeks)
Specialty Pharmacy (2 weeks)
Oncology Infectious Diseases (2 weeks)
Elective Rotations
Pain Management/Palliative Care (2 - 4 weeks)
Disease Specific Ambulatory Clinic (2 - 4 weeks)
Transitions of Care (4 weeks)
Benign Hematology (2 - 4 weeks)
Interest Directed Experience (4 - 6 weeks)
Longitudinal Rotations
Oncology Pharmacy Management (52 weeks with a 2-week focused experience in February, July through June)
Drug Policy/Formulary Management (52 weeks, July through June)
Research (52 weeks, July through June)
Oncology Residency Conference/Teaching (52 weeks, July through June)
Investigational Drug Service (52 weeks, July through June)
Ambulatory Oncology Clinic (Solid and Heme/BMT) (48 weeks, August through June, a half-day weekly)
Leadership Development Series (if not completed during PGY1 year, 52 weeks, July through June)
Service Commitment (Staffing) Experience (52 weeks, July through June)
PGY2 residents are required to fulfill the service commitment (staffing) designed to ensure that residents gain experience and can function as competent clinical oncology practitioners. Each resident will train with preceptors and basic training will take place during the first month of residency.
As part of the service commitment for PGY2 residents, the following staffing requirements apply:
- PGY2 oncology residents will staff 22 shifts throughout the year, approximately two shifts per month that may or may not include weekends and/or evenings.
- PGY2 oncology residents must work one holiday.
- Staffing will occur on the Werner Oncology/Hematology Special Care Unit
Contact
Jared Matya, PharmD, BCOP
Clinical Pharmacist Practitioner – Blood and Marrow Transplant
PGY2 Oncology Residency Program Director
Nebraska Medicine
981090 Nebraska Medical Center
Omaha, NE 68198-1090
Phone: 402-552-3929
Ashley Kenkel, PharmD, BCOP
Pharmacist Specialist - Oncology
PGY2 Oncology Assistant Residency Program Director
Nebraska Medicine
981090 Nebraska Medical Center
Omaha, NE 68198-1090
Phone: 402-552-3929